Novartis Investigative Site

Neenah, Wisconsin 54956

We've found

2 trials

at this facility

Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies

Status: Enrolling, Phase
Updated: 12/31/1969

from

Neenah, WI

A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod

Status: Enrolling, Phase IV
Updated: 12/31/1969

from

Neenah, WI

Use our guide to learn which trials are right for you!